Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05953909
What this trial is testing

Eribulin-Based Regimen Versus Other Chemotherpy in Triple-Negative Metastatic Breast Cancer (ERI-Based-01).

Who this might be right for
Breast Cancer
Fujian Cancer Hospital 120
Testing effectiveness (Phase 2)Ended earlyNCT04095689
What this trial is testing

Docetaxel Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy in Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerAnthracycline-refractory TNBC
The Methodist Hospital Research Institute 8
Testing effectiveness (Phase 2)Study completedNCT02370238
What this trial is testing

Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Dompé Farmaceutici S.p.A 194
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07730125
What this trial is testing

Gene-edited T Regulatory Cells (CRG-150) for the Treatment of Relapsed/Refractory Malignancies

Who this might be right for
HR-positive, HER2-negative Breast CancerTNBC - Triple-Negative Breast CancerProstate Cancer
CoRegen, Inc. 67
Testing effectiveness (Phase 2)Study completedNCT07827079
What this trial is testing

Tislelizumab Combined With TAC Regimen as Neoadjuvant Therapy for TNBC

Who this might be right for
Breast Cancer (Triple Negative Breast Cancer (TNBC))Chemeotherapy
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 36
Not applicableStudy completedNCT06965361
What this trial is testing

Stromal Tumor-Infiltrating Lymphocyte Levels Are Associated With Immune Checkpoint Proteins In Triple Negative Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Who this might be right for
Triple Negative Breast Cancer
Ziauddin University 54
Testing effectiveness (Phase 2)UnknownNCT04755868
What this trial is testing

Talazoparib Maintenance Therapy in Triple-negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Yonsei University 206
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07762703
What this trial is testing

Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
BreakBio Corp 10
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Testing effectiveness (Phase 2)UnknownNCT01732276
What this trial is testing

The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Jiangmen Central Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT02203513
What this trial is testing

A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Ovarian CancerBreast CancerProstate Cancer
National Cancer Institute (NCI) 111
Testing effectiveness (Phase 2)Looking for participantsNCT04437160
What this trial is testing

Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy

Who this might be right for
Triple Negative Breast Cancer
Chinese Academy of Medical Sciences 286
Testing effectiveness (Phase 2)Study completedNCT02413320
What this trial is testing

Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Priyanka Sharma 101
Not applicableUnknownNCT01434420
What this trial is testing

Triple Negative Breast Cancer: Study of Molecular and Genetic Factors

Who this might be right for
Breast Cancer
Institut Paoli-Calmettes 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT03090165
What this trial is testing

Ribociclib and Bicalutamide in AR+ TNBC

Who this might be right for
Triple Negative Breast Cancer
Kari Wisinski 37
Large-scale testing (Phase 3)Looking for participantsNCT05909332
What this trial is testing

Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Fudan University 764
Testing effectiveness (Phase 2)Looking for participantsNCT07623577
What this trial is testing

Sac-TMT Combined With Bevacizumab in TNBC With Brain Metastases

Who this might be right for
TNBCBrain Metastasis
Fudan University 24
Testing effectiveness (Phase 2)Study completedNCT00930930
What this trial is testing

Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 145
Testing effectiveness (Phase 2)UnknownNCT05145907
What this trial is testing

Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors

Who this might be right for
Triple-negative Breast CancerHead and Neck Squamous Cell Carcinoma
TJ Biopharma Co., Ltd. 133
Testing effectiveness (Phase 2)Looking for participantsNCT06657222
What this trial is testing

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsHNSCCSCLC+3 more
Tubulis GmbH 250
Next Page